ВОЗМОЖНОСТИ ЛУЧЕВОЙ ДИАГНОСТИКИ У ПАЦИЕНТОВ С СИНДРОМОМ СОННОГО АПНОЭ

This article examines the literature about possibilities of radiology in patients with snoring and obstructive sleep apnea in ENT and maxillofacial surgery in pediatric patients and adult ages.Проведен анализ данных литературы о возможностях лучевой диагностики феномена храпа и синдрома обструктивного апноэ сна в оториноларингологии и челюстно-лицевой хирургии у пациентов детского и взрослого возраста

Local etiotropic treatment of acute otitis externa and otitis media

According to statistics for the past 25 years, the incidence of acute external otitis media has not decreased. This is a very common disease occurring in all age groups and accounting for over a quarter of all otiatric cases (1, 3, 6, 8, 9). According to certain data, the incidence of otitis externa is from 12.9 to 21% in children with diseases of the ear (1, 3, 10). There has been a significant increase in patients with external otitis recently conditioned by a wide use of headphones, popularity of different water entertainments (swimming pool, water park) and occupational hazards (1, 4, 6, 8). Acute otitis media is one of the most common diseases in children (1, 10). It should be noted that complications of acute otitis media (persistent perforations, adhesions in the tympanic cavity, auditory nerve damage) are a major cause of hearing loss (5)

ВОЗМОЖНОСТИ ЛУЧЕВОЙ ДИАГНОСТИКИ У ПАЦИЕНТОВ С СИНДРОМОМ СОННОГО АПНОЭ

This article examines the literature about possibilities of radiology in patients with snoring and obstructive sleep apnea in ENT and maxillofacial surgery in pediatric patients and adult ages.Проведен анализ данных литературы о возможностях лучевой диагностики феномена храпа и синдрома обструктивного апноэ сна в оториноларингологии и челюстно-лицевой хирургии у пациентов детского и взрослого возраста

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: The ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

Aims: The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. Conclusions: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality

The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry

Aims: The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI. Methods and results: Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected across 196 centres and 29 countries. Among the centres, there were 136 percutaneous coronary intervention centres and 91 with cardiac surgery on-site. The majority of centres (129/196) were part of a STEMI network. The main objective of this study was to describe the demographic, clinical, and angiographic characteristics of patients with STEMI. Other objectives include to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients' outcomes. Patients will be followed for 1 year after admission. Conclusion: The ESC ACCA-EAPCI EORP ACS STEMI registry is an international registry of care and outcomes of patients hospitalized with STEMI. It will provide insights into the contemporary patient profile, management patterns, and 1-year outcome of patients with STEMI